Lawyers Dr. E. Seyfi Moroğlu, LL.M

Dr. E. Seyfi Moroğlu, LL.M

Dr. E. Seyfi Moroğlu, LL.M

Moroğlu Arseven

Seyfi advises companies, funds, financial services companies, banks and shareholders in a wide variety of complex projects or conflicts. He offers strategic support during transactions, disputes, investigations, regulatory compliance, as well as day-to-day commercial and employment matters. Seyfi has a strong track record advising on cross-border corporate and financial transactions, developing tailored contracts and corporate structures to ensure each client’s operations run smoothly in Turkey.

He has significant expertise advising clients during mergers, acquisitions, joint ventures and partnerships as well as disputes and regulatory processes arising therefrom. These transactions frequently involve high-values, or clients dealing with cross-border complications, customised legal structures, along with complicated regulatory, financing or security obstacles.


Practice Areas & Work Department

Joint ventures

Mergers and acquisitions

Regulatory compliance & licensing

Shareholder disputes

Structured finance & securities

Angel investing, private equity, & venture capital

Business set-up

Corporate restructuring

Start-ups & emerging growth

Foreign investment, tax & fiscal regulations

 

Languages

Turkish

English

German

 

Memberships

International Bar Association

Young Businessmen Association of Turkey (TUGİAD)

Robert College Alumni Association

Istanbul University Alumni Association

Entrepreneurs’ Organization (founding board member)

Büyük Kulüp (Circle D’Orient)

Özel Sağlık Tesislerinin Denetimi Hakkında Yönetmelik Yayımlandı

Özel Sağlık Tesislerinin Denetimi Hakkında Yönetmelik (“Yönetmelik“), 17 Kasım 2023 tarihli ve 32372 sayılı Resmî Gazete’de yayımlandı. Sağlık hizmet sunumunun ve sağlık hizmeti sunan gerçek kişiler ile sağlık kurum ve kuruluşlarının ilgili mevzuat ve Sağlık Bakanlığı tarafından belirlenen düzenlemelere uygunluğunun denetimi ve yürütülen denetim sürecinin sonunda tespit edilen aykırılıklara uygulanacak idari yaptırımlara ilişkin usul ve esasları belirlenmiştir.

29.01.2024

Özel Hastaneler Yönetmeliği’nde Değişiklik Yapıldı

Özel Hastaneler Yönetmeliğinde değişiklikler yapılmıştır, değişiklikleri içeren yönetmelik kapsamında yayımlandığı tarihte yürürlüğe girmiştir. 27/3/2002 tarihli ve 24708 sayılı Resmî Gazete’de yayımlanan Özel Hastaneler Yönetmeliğinde Değişiklik Yapılmasına Dair Yönetmelik (“Yönetmelik“), 17 Kasım 2023 tarihli ve 32372 sayılı Resmî Gazete’de yayımlandı.

25.01.2024

Regulation on the Supervision of Private Health Facilities was Introduced

The Regulation on the Supervision of Private Health Facilities (“Regulation“), published in the Official Gazette dated 17 November 2023 and numbered 32372. The procedures and principles regarding the audit of health services and the compliance of real persons providing health services and health institutions, organizations and facilities with the relevant legislation and the regulations determined by the Ministry of Health, and the administrative sanctions to be imposed on the non-compliance detected as a result of the audit process conducted were regulated.

19.01.2024

Amendments to the Regulation on Private Hospitals Were Introduced

The Regulation on Private Hospitals were amended and  and amending regulation entered into force on the date of publication. The Regulation Amending the Regulation on Private Hospitals published in the Official Gazette dated 27/3/2002 and numbered 24708 (“Regulation“), published in the Official Gazette dated 17 November 2023 and numbered 32372.

19.01.2024

5 Years of Best Practice in Competition – Türkiye

We are pleased to release Moroğlu Arseven’s 5 Years of best practice in competition law. This publication aims to offer a comprehensive overview on competition law trends of Türkiye and landmark decisions as there were important developments between the years 2018-2022.Topics covered include: (i) information on the Turkish Competition Authority’s increased information gathering powers and jurisdiction in light of its recent decisional practice, (ii) developments regarding recently introduced commitment and settlement procedures, (iii) the headline figures from 2018-2022, (iv) significant decisions of the Competition Board, and (v) information on current as well as upcoming legislative developments.

29.08.2023

Türkiye İlaç ve Tıbbi Cihaz Kurumu Ortak Pazarlanan Beşeri Tıbbi Ürünlere İlişkin Kılavuz Yayınladı

Beşerî tıbbi ürünlerin güvenlik ve kalitesinin sağlanması amacıyla yayınlanan Beşeri Tıbbi Ürünler Ruhsatlandırma Yönetmeliği, Türkiye İlaç ve Tıbbi Cihaz Kurumu'na kılavuz yayımlama yetkisi vermişti. Bu kapsamda çıkarılan Ortak Pazarlanan Beşerî Tıbbi Ürünlere İlişkin Kılavuz, ortak pazarlama sürecini düzenlemektedir. Kılavuzda, ruhsat başvuruları için gereken belgeler ve başvuru sürecinde dikkat edilmesi gereken hususlar belirtilmiştir. Ayrıca, ana ürünün ruhsatının askıya alınması veya iptal edilmesi durumunda uygulanacak düzenlemeler de yer almaktadır. Kılavuz, 17 Şubat 2023 tarihinde yürürlüğe girmiştir.

31.05.2023

Turkish Medicines and Medical Devices Agency published a Guideline on Co-marketed Medicinal Products for Human Use

The Regulation on Licensing of Medicinal Products for Human Use aims to ensure the security and quality of such products. The Turkish Medicines and Medical Devices Agency (TMMDA) has the authority to issue guidelines for the application of the Regulation. In line with this, the Guideline on Co-marketed Medicinal Products for Human Use has been implemented by TMMDA. The Guideline provides instructions for the licensing and evaluation of co-marketed products, including application requirements, documents to be submitted, and the suspension or cancellation of licenses. It became effective on 17 February 2023.

17.05.2023
Load More
Ready to stay ahead of the curve?
Share your interest anonymously and let us guide you through the informative articles on the hottest legal topics.
|
Successful Your message has been sent